Colorectal Cancer Clinical Trial
Official title:
Improving Surveillance for Colorectal Polyps
RATIONALE: Receiving a reminder letter from their doctor may increase the frequency of
colonoscopy in patients who have had a colorectal polyp removed.
PURPOSE: This randomized clinical trial is studying how well a reminder letter from their
doctor improves the frequency of colonoscopy in patients who have had a colorectal polyp
removed.
OBJECTIVES:
- Determine whether rates of surveillance colonoscopy can be substantially increased by
linking computerized data on endoscopic screening procedures to computerized pathology
data to identify patients with prior adenomatous polyps who are due for repeat
colonoscopy.
- Evaluate whether the impact of the intervention varies by patient characteristics,
including age, sex, or site of primary care.
OUTLINE: This is a randomized, controlled, crossover study. Patients are stratified
according to age (≤ 65 years of age vs > 65 years of age), gender, time elapsed since last
colonoscopy, and primary care physician's (PCP) membership in Harvard Vanguard Medical
Associates (yes vs no). Patients are randomized to 1 of 2 arms.
- Arm I: PCPs are mailed response forms (regarding the disposition of their eligible
patients [e.g. patient letter mailed, patient called, scheduled for colonoscopy,
colonoscopy completed elsewhere, patient refused procedure, clinical contraindication,
patient deceased]) and letters reminding them that their patients are due for a
follow-up colonoscopy. PCPs who do not return response forms within 4 weeks are sent a
second set of reminders and patient letters.
- Arm II: Six months after the beginning of the study, PCPs are mailed response forms and
patient letters once. A second set of reminders and patient letters are not sent.
PROJECTED ACCRUAL: A total of 800 patients will be accrued for this study.
;
Allocation: Randomized
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |